Concepedia

Lauren Ziemba

LZ

Statistics

Publications

4

Citations

213

H-Index

4

Active since

2021

Affiliations

Family Health International 360(Current)

Frontier Science & Technology Research Foundation, Inc.

University of the Witwatersrand

Perinatal HIV Research Unit

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Lauren Ziemba is an author at Family Health International 360 specializing in maternal-fetal medicine, pregnancy, and antiretroviral therapy.

Publications per year

2021–2024

4

Publications

4

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Shahin Lockman, Sean S. Brummel, Lauren Ziemba et al. · The Lancet · 2021 · 160 citations · Full text

, , +16

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Lameck Chinula, Lauren Ziemba, Sean S. Brummel et al. · The Lancet HIV · 2023 · 29 citations · Full text

, , +16

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

Kristina M. Brooks, Jennifer J. Kiser, Lauren Ziemba et al. · The Lancet HIV · 2023 · 12 citations · Full text

, , +17

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Risa M. Hoffman, Sean S. Brummel, Lauren Ziemba et al. · Clinical Infectious Diseases · 2024 · 12 citations · Full text

, , +17

1–4 of 4